Is RVL Pharmaceuticals PLC halal to invest in?

According to Musaffa's Shariah screening methodology, RVL Pharmaceuticals PLC (RVLPQ) is currently classified as NOT HALAL as of August 2023. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is RVL Pharmaceuticals PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes RVL Pharmaceuticals PLC using these criteria to determine its compliance status.

Can Muslims buy shares of RVL Pharmaceuticals PLC?

Muslim investors may consider investing in RVL Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is RVL Pharmaceuticals PLC classified as NOT HALAL?

Musaffa determines the Shariah status of RVL Pharmaceuticals PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for RVL Pharmaceuticals PLC updated?

The Shariah compliance status of RVL Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like RVL Pharmaceuticals PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of RVL Pharmaceuticals PLC?

You can check the latest Shariah compliance status of RVL Pharmaceuticals PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RVLPQ Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: August 28, 2023

Report Source: 2023 2nd Quarter Report

Analyst's Ratings for RVL Pharmaceuticals PLC (RVLPQ)

Based on 11 analysts giving stock ratings to RVL Pharmaceuticals PLC in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

RVL Pharmaceuticals PLC. Stock Analysis RVLPQ

United States Health Care Nano Cap Report: Q2, 2023

RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The firm is focused on developing and commercializing products for an underserved patient population in ocular medicine and medical aesthetics. The company operates in one business segment which focuses on developing and commercializing pharmaceutical products. The firm is commercializing Upneeq for treating acquired blepharoptosis (low-lying eyelids) in adults and is developing Arbaclofen ER tablets for alleviating spasticity in multiple sclerosis patients. Their healthcare provider customers include optometrists, ophthalmologists, oculoplastic surgeons, facial plastic surgeons, dermatologists, and other qualified practitioners. The target patient population comprises adults with droopy or low-lying eyelids, primarily females. Its commercial operations are managed by wholly owned subsidiaries, RVL Pharmaceuticals, Inc., and RVL Pharmacy, LLC.

Financial Metrics & Statements of RVL Pharmaceuticals PLC (RVLPQ)

FAQ's for RVL Pharmaceuticals PLC (RVLPQ)

According to Musaffa’s Shariah screening methodology, RVL Pharmaceuticals PLC (RVLPQ) is currently classified as NOT HALAL as of August 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.